Risk of pneumonitis in patients with advanced NSCLC treated with pembrolizumab in KEYNOTE-001 Meeting Abstract


Authors: Ahn, M. J.; Gandhi, L.; Hamid, O.; Hellmann, M. D.; Garon, E. B.; Ramalingam, S. S.; Lubiniecki, G. M.; Zhang, J.; Piperdi, B.; Hui, R.
Abstract Title: Risk of pneumonitis in patients with advanced NSCLC treated with pembrolizumab in KEYNOTE-001
Meeting Title: ESMO Asia 2015 Congress
Journal Title: Annals of Oncology
Volume: 26
Issue: Suppl. 9
Meeting Dates: 2015 Dec 18-21
Meeting Location: Singapore
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2015-12-01
Start Page: ix140
Language: English
ACCESSION: WOS:000367158700458
PROVIDER: wos
DOI: 10.1093/annonc/mdv532.43
Notes: Meeting Abstract: 459P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Matthew David Hellmann
    411 Hellmann